Muñoz Melba, Schoepke Nicole, Altrichter Sabine, Staubach Petra, Geppert-Steidl Clara, Durner Leslie, Bernstein Jonathan A, Maurer Marcus, Weller Karsten
Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, and Humboldt-Universität zu Berlin, Mainz, Germany.
Immunology and Allergology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Mainz, Germany.
Clin Transl Allergy. 2025 Feb;15(2):e70038. doi: 10.1002/clt2.70038.
Symptomatic Dermographism (SD), also known as "urticaria factitia", is the most common subtype of chronic inducible urticaria. Affected patients develop itch and strip-shaped wheals that usually last for 30 min after minor stroking, rubbing, or scratching of the skin. The quality of life (QoL) of patients with SD is often strongly affected. However, a QoL instrument to properly assess this impairment is not yet available.
The aim of this study was to develop the first disease-specific patient reported outcome measure|patient reported outcome measures (PROM) to evaluate QoL impairment in SD patients, the Symptomatic Dermographism Quality of Life Questionnaire (SD-QoL).
SD-QoL was developed following current guidelines for PROM development. We first generated a hypothetical conceptional framework of the SD-QoL, followed by an item generation and an item selection/reduction phase.
During the item generation phase, 69 potential items of the SD-QoL were generated by applying a combined approach consisting of literature review, expert input as well as semi-structured interviews with affected patients. During the item selection phase, we reduced this long list of items to a final 13-item set by means of impact analysis, inter-item correlation, and additional criteria for item reduction, including an expert review for content (face) validity. Finally, a US-American-English version of the SD-QoL was developed using a structured translation process.
The SD-QoL is the first disease-specific-QoL instrument for SD with a recall period of 7 days that allows the assessment of QoL in SD patients. A subsequent validation study will determine its validity and reliability.
症状性皮肤划痕症(SD),也称为“人工性荨麻疹”,是慢性诱导性荨麻疹最常见的亚型。受影响的患者在皮肤受到轻微抚摸、摩擦或搔抓后会出现瘙痒和条索状风团,通常持续30分钟。SD患者的生活质量(QoL)常受到严重影响。然而,目前尚无一种能准确评估这种损害的生活质量评估工具。
本研究的目的是开发首个针对疾病的患者报告结局测量工具|患者报告结局测量工具(PROM),以评估SD患者的生活质量损害,即症状性皮肤划痕症生活质量问卷(SD-QoL)。
SD-QoL是根据当前PROM开发指南制定的。我们首先构建了一个SD-QoL的假设概念框架,随后进入条目生成和条目选择/简化阶段。
在条目生成阶段,通过文献综述、专家意见以及对受影响患者进行半结构式访谈相结合的方法,生成了69个SD-QoL潜在条目。在条目选择阶段,我们通过影响分析、条目间相关性以及其他条目简化标准,包括专家对内容(表面)效度的审查,将这一长串条目缩减为最终的13个条目集。最后,通过结构化翻译流程开发了SD-QoL的美式英语版本。
SD-QoL是首个针对SD的特定疾病生活质量评估工具,回顾期为7天,可用于评估SD患者的生活质量。后续的验证研究将确定其效度和信度。